Bo Fu Selected Research

tetra(4-N-methylpyridyl)porphine

1/2022	VEGF aptamer/i-motif-grafted multi-functional SPION nanocarrier for chemotherapeutic/phototherapeutic synergistic research.
12/2021	VEGF aptamer/i-motif-based drug co-delivery system for combined chemotherapy and photodynamic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Fu Research Topics

Disease

21	Neoplasms (Cancer) 02/2022 - 08/2008
13	Infections 01/2022 - 03/2005
11	Inflammation (Inflammations) 01/2022 - 06/2008
10	Fibrosis (Cirrhosis) 07/2022 - 06/2008
9	Neoplasm Metastasis (Metastasis) 02/2022 - 11/2011
9	Rheumatoid Arthritis 11/2016 - 01/2011
8	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2011
6	Nephritis 06/2021 - 01/2016
5	Necrosis 01/2020 - 06/2014
5	Arthritis (Polyarthritis) 11/2016 - 04/2010
4	Hemorrhage 01/2021 - 04/2013
4	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 06/2014
4	Diabetic Nephropathies (Diabetic Nephropathy) 03/2014 - 06/2006
3	Wounds and Injuries (Trauma) 01/2022 - 04/2012
3	Hypoxia (Hypoxemia) 08/2020 - 01/2014
3	Hyperuricemia 01/2020 - 05/2012
3	Glomerulonephritis 01/2019 - 01/2016
3	Ischemia 01/2018 - 01/2014
3	Hyperplasia 01/2017 - 06/2011
3	Sepsis (Septicemia) 01/2017 - 02/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 01/2022
2	Carcinogenesis 01/2021 - 10/2020
2	Lymphatic Metastasis 06/2020 - 01/2015
2	Hodgkin Disease (Hodgkin's Disease) 11/2018 - 10/2013
2	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2018 - 01/2013
2	Neuralgia (Stump Neuralgia) 01/2018 - 04/2017
2	Ischemic Stroke 01/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 11/2011
2	Type 2 Diabetes Mellitus (MODY) 07/2014 - 11/2012
2	Heart Failure 11/2013 - 06/2013
2	Hyperglycemia 01/2012 - 01/2007
2	Hypertrophy 01/2012 - 01/2011
2	Leukemia 04/2010 - 08/2008
2	Ureteral Obstruction 06/2008 - 05/2002
1	Central Serous Chorioretinopathy 09/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2008
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
9	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 06/2006
8	Pharmaceutical PreparationsIBA 01/2022 - 03/2013
5	CytokinesIBA 01/2022 - 01/2015
5	Peptides (Polypeptides)IBA 10/2020 - 06/2012
5	AntibodiesIBA 01/2018 - 11/2011
5	Tissue Inhibitor of Metalloproteinase-1IBA 02/2015 - 05/2002
4	MicroRNAs (MicroRNA)IBA 03/2022 - 10/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2018
4	Messenger RNA (mRNA)IBA 01/2019 - 06/2014
4	Antiviral Agents (Antivirals)IBA 01/2018 - 12/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2015 - 03/2013
3	Adenosine Triphosphate (ATP)IBA 06/2022 - 11/2008
3	Biological ProductsIBA 03/2022 - 03/2013
3	EnzymesIBA 01/2022 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2017
3	Circular RNAIBA 01/2021 - 12/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2016
3	Indicators and Reagents (Reagents)IBA 08/2020 - 12/2015
3	InterleukinsIBA 01/2020 - 12/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 06/2011
3	NitrogenIBA 01/2020 - 06/2014
3	Urea (Carbamide)FDA LinkGeneric 01/2020 - 06/2014
3	CreatinineIBA 01/2018 - 06/2014
3	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 01/2016
3	pibrentasvirIBA 01/2018 - 01/2016
3	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2016 - 07/2014
3	Connexin 43 (Connexin43)IBA 03/2014 - 06/2006
3	Small Interfering RNA (siRNA)IBA 01/2011 - 08/2008
2	Long Noncoding RNAIBA 03/2022 - 06/2020
2	Tumor Biomarkers (Tumor Markers)IBA 02/2022 - 01/2022
2	tetra(4-N-methylpyridyl)porphineIBA 01/2022 - 12/2021
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 06/2021
2	HDL CholesterolIBA 11/2021 - 07/2014
2	Oxygen (Dioxygen)IBA 11/2021 - 01/2018
2	anti-Thy antibodyIBA 06/2021 - 01/2017
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 07/2020 - 03/2020
2	LipidsIBA 06/2020 - 07/2014
2	Uric Acid (Urate)IBA 01/2020 - 01/2014
2	RNA (Ribonucleic Acid)IBA 12/2018 - 01/2017
2	InterferonsIBA 01/2018 - 12/2015
2	glecaprevir and pibrentasvirIBA 01/2018 - 01/2018
2	glecaprevirIBA 01/2018 - 01/2018
2	paritaprevirIBA 02/2016 - 01/2016
2	Ritonavir (Norvir)FDA Link 02/2016 - 01/2016
2	Carrier Proteins (Binding Protein)IBA 02/2016 - 11/2014
2	Antirheumatic Agents (DMARD)IBA 01/2016 - 04/2010
2	Insulin-Like PeptidesIBA 07/2014 - 11/2012
2	Insulin-Like Growth Factor Binding Protein 2IBA 07/2014 - 11/2012
2	Matrix Metalloproteinases (MMPs)IBA 06/2014 - 06/2008
2	C-Reactive ProteinIBA 06/2014 - 01/2014
2	Streptozocin (Streptozotocin)FDA Link 12/2013 - 01/2007
2	TOR Serine-Threonine KinasesIBA 01/2013 - 01/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2010 - 08/2008
1	Verteporfin (Visudyne)FDA Link 09/2022

Therapy/Procedure

13	Therapeutics 04/2022 - 01/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 08/2008
2	Renal Dialysis (Hemodialysis) 04/2022 - 11/2021
2	Radiotherapy 02/2022 - 01/2022
2	Transcatheter Aortic Valve Replacement 08/2021 - 07/2020
2	Neoadjuvant Therapy 08/2020 - 10/2016
1	Photochemotherapy (Photodynamic Therapy) 09/2022